Loading…
ImageneBio, Inc. is projected to rise to $5.74 by 2027, a +3% move from its current price of $5.55. IMA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 6/10/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jun 11 | $5.39 | $5.55 | $5.72 | -0.01% |
| Jun 12 | $5.32 | $5.55 | $5.79 | -0.02% |
| Jun 13 | $5.27 | $5.55 | $5.84 | -0.03% |
| Jun 14 | $5.22 | $5.55 | $5.89 | -0.04% |
| Jun 15 | $5.19 | $5.55 | $5.93 | -0.05% |
| Jun 16 | $5.15 | $5.55 | $5.97 | -0.05% |
| Jun 17 | $5.12 | $5.55 | $6.00 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.12 | $5.55 | $6.00 | -0.06% |
| Week 2 | $4.95 | $5.54 | $6.20 | -0.13% |
| Week 3 | $4.83 | $5.54 | $6.36 | -0.19% |
| Week 4 | $4.72 | $5.54 | $6.49 | -0.25% |
| Week 5 | $4.63 | $5.53 | $6.61 | -0.31% |
| Week 6 | $4.55 | $5.53 | $6.72 | -0.38% |
| Week 7 | $4.48 | $5.53 | $6.82 | -0.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc.
and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
ImageneBio, Inc. (IMA) is a healthcare stock currently priced at $5.56. It has a market cap of $62.71M and is ranked 4490. These fundamentals place the stock among smaller-cap healthcare names.
The year-by-year forecast suggests a path of gradual upside, with 2026 carrying an average price of $5.56 and longer-horizon strength developing from 2032 onward, culminating in a 2050 average price near $19.37 and notable ROIs in later years.
A major floor 18.0% below — a decisive break under it would weaken the trend.
The nearest floor, 5.4% below — buyers have tended to step in here.
The nearest ceiling, 9.5% above — a clean break opens room to run.
A major ceiling 35.3% above — clearing it would confirm fresh momentum.
Key IMA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.57 | Sell | $5.62 | Sell |
| MA 10 | $5.69 | Sell | $5.63 | Sell |
| MA 20 | $5.65 | Sell | $5.65 | Sell |
| MA 50 | $5.56 | Sell | $5.73 | Sell |
| MA 100 | $6.05 | Sell | $6.18 | Sell |
| MA 200 | $7.08 | Sell | $7.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.21 | Neutral |
| Stoch RSI (14) | 55.42 | Neutral |
| CCI (20) | -8.40 | Neutral |
| Williams %R (14) | -44.12 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 4.07 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 55.88 | Neutral |
| TRIX (15) | -0.02 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 38.78 | Neutral |
| Momentum (10) | 0.07 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 5.59 | Sell |
| ADX (14) | 8.01 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is bearish. RSI14 is 50, with the 50-day simple moving average at $5.57 and the 200-day simple moving average at $7.52. Support is at $5.25 and resistance at $6.08, framing a modestly range-bound setup in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.55 | $5.55 | $7.09 | 0% | Neutral | |
| $4.52 | $5.74 | $7.76 | +3% | Neutral | |
| $3.97 | $5.20 | $7.31 | -6% | Neutral | |
| $4.20 | $5.65 | $8.18 | +2% | Neutral | |
| $4.37 | $6.01 | $8.93 | +8% | Neutral | |
| $4.50 | $6.32 | $9.60 | +14% | Neutral | |
| $5.42 | $7.75 | $12.03 | +40% | Bullish | |
| $5.55 | $8.08 | $12.78 | +46% | Bullish | |
| $5.28 | $7.83 | $12.58 | +41% | Bullish | |
| $5.32 | $8.02 | $13.09 | +44% | Bullish | |
| $7.06 | $11.48 | $20.02 | +107% | Bullish | |
| $9.64 | $17.89 | $34.31 | +222% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| June 2026 | $4.55 | $5.55 | $6.68 | +0.00% |
| July 2026 | $4.62 | $5.47 | $6.66 | -1.50% |
| August 2026 | $4.61 | $5.50 | $6.79 | +0.69% |
| September 2026 | $4.75 | $5.71 | $7.10 | +3.68% |
| October 2026 | $4.71 | $5.68 | $7.14 | -0.39% |
| November 2026 | $4.55 | $5.52 | $6.99 | -2.82% |
| December 2026 | $4.56 | $5.56 | $7.09 | +0.66% |
Click any year to see its month-by-month IMA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, IMA is projected to trade between $4.55 and $7.09, averaging $5.55 — a potential gain of 0% from today's $5.55. Price action looks broadly range-bound.
ImageneBio, Inc.'s 2027 outlook centres on $5.74, within a $4.52 to $7.76 range. That is up +3% on the projected 2026 average. That marks a +3% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, IMA could reach as high as $7.31, with a base case around $5.20 and support toward $3.97 — roughly -6% from $5.55. Price action looks broadly range-bound.
Expect IMA to range from $4.20 to $8.18 through 2029. The $5.65 average target implies a +2% move from current prices. That is up +9% on the projected 2028 average. A consolidation phase looks the most probable path here.
The IMA price prediction for 2030 points to an average of $6.01 (low $4.37, high $8.93) — a potential gain of +8% on today's $5.55. Price action looks broadly range-bound.
In 2031, IMA is projected to trade between $4.50 and $9.60, averaging $6.32 — a potential gain of +14% from today's $5.55. That is up +5% on the projected 2030 average. A consolidation phase looks the most probable path here.
ImageneBio, Inc.'s 2032 outlook centres on $7.75, within a $5.42 to $12.03 range. That is up +23% on the projected 2031 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2033, IMA could reach as high as $12.78, with a base case around $8.08 and support toward $5.55 — roughly +46% from $5.55. Buyers look set to stay in control over this stretch.
Expect IMA to range from $5.28 to $12.58 through 2034. The $7.83 average target implies a +41% move from current prices. That is -3% versus the projected 2033 average. Momentum favours further upside here.
The IMA price prediction for 2035 points to an average of $8.02 (low $5.32, high $13.09) — a potential gain of +44% on today's $5.55. Buyers look set to stay in control over this stretch.
In 2040, IMA is projected to trade between $7.06 and $20.02, averaging $11.48 — a potential gain of +107% from today's $5.55. That is up +43% on the projected 2035 average. Momentum favours further upside here.
ImageneBio, Inc.'s 2050 outlook centres on $17.89, within a $9.64 to $34.31 range. That is up +56% on the projected 2040 average. That marks a +222% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in IMA today (≈ 180.18018 IMA) could be worth
$3,223.84
+$2,223.84 (+222%) by 2050 · US Dollar
Based on the average projected IMA price of $17.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMAwould be worth at today's price.
$1,000 invested in IMA on Jun 9, 2025 (≈ 56.689344 IMA) would be worth
$314.63
-$685.37 (-68.5%) today · 0.31× · US Dollar
Based on a IMA entry price of $17.64 vs. today's $5.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.47 | $1,014.63 | +1.5% |
| 1 month ago | $5.29 | $1,049.15 | +4.9% |
| 3 months ago | $6.07 | $914.33 | -8.6% |
| 6 months ago | $6.43 | $863.14 | -13.7% |
| 1 year ago | $17.64 | $314.63 | -68.5% |
| All time (5.0y) ago | $174.6 | $31.79 | -96.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMA forecast.
Our base-case forecast reaches $11.00 around 2040.
Implied market cap at $11.00: $124.07M
The multi-year forecast shows a gradual rise in average price from 2026 onward, with 2030 to 2050 staying in a bullish trajectory. The 2030 average price is $6.05, and the 2040 average price is $12.33, rising further to a 2050 average of $19.37. Notably, the forecast forecasts robust ROIs later in the horizon: 8.8% in 2030, 18.2% in 2031, 50% in 2032, 51.2% in 2033, 44.9% in 2034, 52.7% in 2035, 121.8% in 2040 and 248.4% in 2050.
Sentiment shifts from Neutral in 2026–2031 to Bullish from 2032 onward, indicating a stronger longer-term upside potential, tempered by the earlier years’ moderation and volatility.
Tap a question to reveal the answer.
In 2030 the min is $4.28, the avg is $6.05 and the max is $9.24, with a projected ROI of 8.8% and Neutral sentiment.
The outlook shows Neutral sentiment through 2026–2031, then Bullish from 2032 onward. Key annual ROIs include 18.2% in 2031, 50% in 2032, 51.2% in 2033, 44.9% in 2034, 52.7% in 2035, 121.8% in 2040 and 248.4% in 2050, suggesting upside potential with varying near-term risk.
Yes. The forecasted max prices reach $22.41 in 2040 and $38.98 in 2050, with the 2050 average near $19.37. This indicates the possibility of crossing the $20 level in the mid-to-late horizon.
The near-term data show Neutral sentiment and modest returns, with a 60% annualized volatility. There are years with negative ROI (e.g., -6% in 2028) and a pattern of variable yearly moves before longer-term bullish shifts, so outcomes are uncertain and not guaranteed.
For 2027, the min is $4.38, the avg is $5.66 and the max is $7.79, with a projected ROI of 1.7% and Neutral sentiment.
ImageneBio, Inc. Community Discussion
0Share your ImageneBio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.